ADESSO SE (ADN1.DE) Fundamental Analysis & Valuation

FRA:ADN1 • DE000A0Z23Q5

Current stock price

63.2 EUR
+1.9 (+3.1%)
Last:

This ADN1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ADN1.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ADN1 was profitable.
  • In the past year ADN1 had a positive cash flow from operations.
  • Each year in the past 5 years ADN1 has been profitable.
  • ADN1 had a positive operating cash flow in each of the past 5 years.
ADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • ADN1 has a Return On Assets (2.45%) which is comparable to the rest of the industry.
  • The Return On Equity of ADN1 (10.90%) is comparable to the rest of the industry.
  • ADN1 has a Return On Invested Capital (5.23%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ADN1 is significantly below the industry average of 11.58%.
  • The last Return On Invested Capital (5.23%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.45%
ROE 10.9%
ROIC 5.23%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ADN1.DE Yearly ROA, ROE, ROICADN1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • With a Profit Margin value of 0.99%, ADN1 is not doing good in the industry: 62.34% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of ADN1 has declined.
  • ADN1's Operating Margin of 2.96% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.94% of its industry peers.
  • ADN1's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 85.30%, ADN1 is doing good in the industry, outperforming 77.92% of the companies in the same industry.
  • ADN1's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.96%
PM (TTM) 0.99%
GM 85.3%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
ADN1.DE Yearly Profit, Operating, Gross MarginsADN1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. ADN1.DE Health Analysis

2.1 Basic Checks

  • ADN1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ADN1 has more shares outstanding
  • ADN1 has a better debt/assets ratio than last year.
ADN1.DE Yearly Shares OutstandingADN1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ADN1.DE Yearly Total Debt VS Total AssetsADN1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ADN1 has an Altman-Z score of 3.46. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
  • ADN1 has a better Altman-Z score (3.46) than 83.12% of its industry peers.
  • ADN1 has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as ADN1 would need 7.88 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.88, ADN1 is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.60 is on the high side and indicates that ADN1 has dependencies on debt financing.
  • ADN1 has a worse Debt to Equity ratio (1.60) than 75.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 7.88
Altman-Z 3.46
ROIC/WACC1
WACC5.25%
ADN1.DE Yearly LT Debt VS Equity VS FCFADN1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
  • ADN1's Current ratio of 1.30 is in line compared to the rest of the industry. ADN1 outperforms 59.74% of its industry peers.
  • ADN1 has a Quick Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, ADN1 is in the better half of the industry, outperforming 62.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
ADN1.DE Yearly Current Assets VS Current LiabilitesADN1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

8

3. ADN1.DE Growth Analysis

3.1 Past

  • ADN1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.98%, which is quite impressive.
  • The earnings per share for ADN1 have been decreasing by -15.02% on average. This is quite bad
  • The Revenue has grown by 12.60% in the past year. This is quite good.
  • Measured over the past years, ADN1 shows a very strong growth in Revenue. The Revenue has been growing by 23.60% on average per year.
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%

3.2 Future

  • ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.90% yearly.
  • The Revenue is expected to grow by 10.64% on average over the next years. This is quite good.
EPS Next Y79.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
EPS Next 5Y40.9%
Revenue Next Year11.29%
Revenue Next 2Y11.36%
Revenue Next 3Y10.95%
Revenue Next 5Y10.64%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ADN1.DE Yearly Revenue VS EstimatesADN1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ADN1.DE Yearly EPS VS EstimatesADN1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10

6

4. ADN1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.81, the valuation of ADN1 can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ADN1 is on the same level as its industry peers.
  • ADN1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.66.
  • The Price/Forward Earnings ratio is 12.12, which indicates a correct valuation of ADN1.
  • ADN1's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ADN1 is cheaper than 70.13% of the companies in the same industry.
  • ADN1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.00.
Industry RankSector Rank
PE 19.81
Fwd PE 12.12
ADN1.DE Price Earnings VS Forward Price EarningsADN1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ADN1 is valued cheaper than 80.52% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 5.29
ADN1.DE Per share dataADN1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • ADN1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ADN1's earnings are expected to grow with 57.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y69.09%
EPS Next 3Y57.86%

5

5. ADN1.DE Dividend Analysis

5.1 Amount

  • ADN1 has a Yearly Dividend Yield of 1.28%. Purely for dividend investing, there may be better candidates out there.
  • The stock price of ADN1 dropped by -27.37% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • ADN1's Dividend Yield is comparable with the industry average which is at 2.57.
  • ADN1's Dividend Yield is slightly below the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

  • On average, the dividend of ADN1 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years1
Div Non Decr Years7
ADN1.DE Yearly Dividends per shareADN1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • ADN1 pays out 31.75% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ADN1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
ADN1.DE Yearly Income VS Free CF VS DividendADN1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADN1.DE Dividend Payout.ADN1.DE Dividend Payout, showing the Payout Ratio.ADN1.DE Dividend Payout.PayoutRetained Earnings

ADN1.DE Fundamentals: All Metrics, Ratios and Statistics

ADESSO SE

FRA:ADN1 (4/22/2026, 12:47:14 PM)

63.2

+1.9 (+3.1%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-31
Earnings (Next)05-11
Inst Owners19.56%
Inst Owner ChangeN/A
Ins Owners50.29%
Ins Owner ChangeN/A
Market Cap412.70M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target116.45 (84.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.69%
PT rev (3m)-10.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 19.81
Fwd PE 12.12
P/S 0.2
P/FCF 8.83
P/OCF 5.31
P/B 2.16
P/tB 8.15
EV/EBITDA 5.29
EPS(TTM)3.19
EY5.05%
EPS(NY)5.21
Fwd EY8.25%
FCF(TTM)7.16
FCFY11.33%
OCF(TTM)11.9
OCFY18.82%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.25
PEG (5Y)N/A
Graham Number45.8353 (-27.48%)
Profitability
Industry RankSector Rank
ROA 2.45%
ROE 10.9%
ROCE 11.91%
ROIC 5.23%
ROICexc 5.78%
ROICexgc 8.22%
OM 2.96%
PM (TTM) 0.99%
GM 85.3%
FCFM 2.22%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 7.88
Debt/EBITDA 2.26
Cap/Depr 42.37%
Cap/Sales 1.47%
Interest Coverage 5.03
Cash Conversion 57.42%
Profit Quality 224.33%
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 3.46
F-Score7
WACC5.25%
ROIC/WACC1
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y79.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
EPS Next 5Y40.9%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year11.29%
Revenue Next 2Y11.36%
Revenue Next 3Y10.95%
Revenue Next 5Y10.64%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year308.27%
EBIT Next 3Y79.99%
EBIT Next 5Y45.14%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%

ADESSO SE / ADN1.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.


Can you provide the valuation status for ADESSO SE?

ChartMill assigns a valuation rating of 6 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.


How profitable is ADESSO SE (ADN1.DE) stock?

ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.


What is the financial health of ADESSO SE (ADN1.DE) stock?

The financial health rating of ADESSO SE (ADN1.DE) is 4 / 10.


Can you provide the dividend sustainability for ADN1 stock?

The dividend rating of ADESSO SE (ADN1.DE) is 5 / 10 and the dividend payout ratio is 31.75%.